Skip to main content
SpringerLink
Log in

Drug delivery: Week-long diabetes therapy

  • News & Views
  • Published:

From Nature Biomedical Engineering

View current issue Submit your manuscript

A subcutaneous depot of a diabetes drug fused to a thermosensitive biopolymer leads to blood-glucose control, for over one week after a single injection, in animal models of type-2 diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Long-acting release of an analogue of the glucagon-like peptide-1 receptor agonist via fusion with a thermosensitive elastin-like polypeptide.

References

  1. Ismail-Beigi, F. N. Engl. J. Med. 366, 1319–1327 (2012).

    Article  CAS  Google Scholar 

  2. Meloni, A. R., DeYoung, M. B., Lowe, C. & Parkes, D. G. Diabetes Obes. Metab. 15, 15–27 (2013).

    Article  CAS  Google Scholar 

  3. Gupta, V. Indian J. Endocrinol. Metab. 17, 413–421 (2013).

    CAS  Google Scholar 

  4. Luginbuhl, K. M. Nat. Biomed. Eng. 1, 0078 (2017).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bioengineering, Rice University, 6100 Main Street, Houston, 77030, Texas, USA

    Omid Veiseh

Authors
  1. Omid Veiseh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Omid Veiseh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Veiseh, O. Drug delivery: Week-long diabetes therapy. Nat Biomed Eng 1, 0090 (2017). https://doi.org/10.1038/s41551-017-0090

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41551-017-0090

  • Springer Nature Limited

Search

Navigation